Weaver Consulting Group

SEC CIK: 0001780055
Latest filing: Jul 29, 2026

SEC filings (opens in a new tab)

AVXL holding history

Anavex Life Sciences Corp. in every 13F filed by Weaver Consulting Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVXL overview All 13F holders of AVXL Full Q2 2026 holdings

Shares (Q4 2025): 0; Sold out in Q4 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2025

Holdings of AVXL by Weaver Consulting Group, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2025	0	$0	0.0%	−10,796−100.0%	Sold out	Holders
Q3 2025	10,796	$96.1K	<0.1%	+630+6.2%	Added	Holders
Q2 2025	10,166	$93.7K	<0.1%	+10,166	New	Holders